Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors.
Horikawa H, Kurihara Y, Funakoshi T, Umegaki-Arao N, Takahashi H, Kubo A, Tanikawa A, Kodani N, Minami Y, Meguro S, Itoh H, Izumi K, Nishie W, Shimizu H, Amagai M, Yamagami J.
Horikawa H, et al.
Br J Dermatol. 2018 Jun;178(6):1462-1463. doi: 10.1111/bjd.16479. Epub 2018 Apr 16.
Br J Dermatol. 2018.
PMID: 29478242
No abstract available.